J Eroukhmanoff, I Tejedor, I Potorac, T. Cuny, J. Bonneville, et al.. MRI follow-up is unnecessary in patients with macroprolactinomas and long-term normal prolactin levels on dopamine agonist treatment.
European Journal of Endocrinology, BioScientifica, 2017, 176 (3), pp.323 - 328.
⟨10.1530/EJE-16-0897⟩.
⟨hal-01724182⟩